"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at Clovo
We would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at Mildtech
Some grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at Curenetics
Ailsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at ClovoWe would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at MildtechSome grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at CureneticsAilsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at ClovoWe would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at MildtechSome grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at CureneticsAilsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at ClovoWe would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at MildtechSome grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at CureneticsAilsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health
"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at ClovoWe would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at MildtechSome grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at CureneticsAilsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at ClovoWe would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at MildtechSome grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at CureneticsAilsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at ClovoWe would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at MildtechSome grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at CureneticsAilsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at ClovoWe would not have achieved the grant without Ailsa. They handled the entire process, saved us significant time, and ensured all key criteria were met.
Vasos Vanezi
Co-Founder & CEO at MildtechSome grant-writing incumbents are expensive and misaligned. Ailsa has completely changed the business model. Their approach is personalised, professional, and deeply knowledgeable.
Dr Sola Adeleke
CEO & Chief Medical Officer at CureneticsAilsa constantly scans the market for appropriate opportunities and provides tailored application support. It’s felt like great value for money.
Grace Gimson
Founder & CEO at Holly Health
"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at Clovo"We were absolutely thrilled with the support we received from Ailsa and would not have achieved our grant without them.
They handled the entire grant-writing process, which saved us a significant amount of time and ensured all the key criteria were met.
We are extremely grateful for their support and couldn’t recommend them enough!"Vasos Vanezi
Co-Founder & CEO at Mildtech"Some grant-writing incumbents are expensive; they charge a substantial upfront fee without guaranteeing high-quality work...
Ailsa has completely changed the business model.
Ailsa’s approach is personalised, professional, and comprehensive. They understand the med-tech and biotech grant funding space very well, and they will handle your work with utmost attention and expertise."Dr Sola Adeleke
CEO & Chief Medical Officer at Curenetics"It's been great working with the Ailsa team so far - they are constantly scanning the market for appropriate opportunities, and provide tailored application writing support for a wide variety of opportunities. Given the team's experience (including with health tech specifically) and the level of support, it has felt like great value for money - recommended for time limited orgs looking to maximise their opportunities."
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at Clovo"We were absolutely thrilled with the support we received from Ailsa and would not have achieved our grant without them.
They handled the entire grant-writing process, which saved us a significant amount of time and ensured all the key criteria were met.
We are extremely grateful for their support and couldn’t recommend them enough!"Vasos Vanezi
Co-Founder & CEO at Mildtech"Some grant-writing incumbents are expensive; they charge a substantial upfront fee without guaranteeing high-quality work...
Ailsa has completely changed the business model.
Ailsa’s approach is personalised, professional, and comprehensive. They understand the med-tech and biotech grant funding space very well, and they will handle your work with utmost attention and expertise."Dr Sola Adeleke
CEO & Chief Medical Officer at Curenetics"It's been great working with the Ailsa team so far - they are constantly scanning the market for appropriate opportunities, and provide tailored application writing support for a wide variety of opportunities. Given the team's experience (including with health tech specifically) and the level of support, it has felt like great value for money - recommended for time limited orgs looking to maximise their opportunities."
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at Clovo"We were absolutely thrilled with the support we received from Ailsa and would not have achieved our grant without them.
They handled the entire grant-writing process, which saved us a significant amount of time and ensured all the key criteria were met.
We are extremely grateful for their support and couldn’t recommend them enough!"Vasos Vanezi
Co-Founder & CEO at Mildtech"Some grant-writing incumbents are expensive; they charge a substantial upfront fee without guaranteeing high-quality work...
Ailsa has completely changed the business model.
Ailsa’s approach is personalised, professional, and comprehensive. They understand the med-tech and biotech grant funding space very well, and they will handle your work with utmost attention and expertise."Dr Sola Adeleke
CEO & Chief Medical Officer at Curenetics"It's been great working with the Ailsa team so far - they are constantly scanning the market for appropriate opportunities, and provide tailored application writing support for a wide variety of opportunities. Given the team's experience (including with health tech specifically) and the level of support, it has felt like great value for money - recommended for time limited orgs looking to maximise their opportunities."
Grace Gimson
Founder & CEO at Holly Health"Ailsa’s support has been invaluable in navigating the complex grant landscape.
Their expert guidance and tailored application drafting saved us huge amounts of time and helped us put together a much stronger submission than we could have managed alone.
I would definitely recommend to any early-stage start-ups looking to secure non-dilutive funding."Rory Skinner
Co-Founder & CEO at Clovo"We were absolutely thrilled with the support we received from Ailsa and would not have achieved our grant without them.
They handled the entire grant-writing process, which saved us a significant amount of time and ensured all the key criteria were met.
We are extremely grateful for their support and couldn’t recommend them enough!"Vasos Vanezi
Co-Founder & CEO at Mildtech"Some grant-writing incumbents are expensive; they charge a substantial upfront fee without guaranteeing high-quality work...
Ailsa has completely changed the business model.
Ailsa’s approach is personalised, professional, and comprehensive. They understand the med-tech and biotech grant funding space very well, and they will handle your work with utmost attention and expertise."Dr Sola Adeleke
CEO & Chief Medical Officer at Curenetics"It's been great working with the Ailsa team so far - they are constantly scanning the market for appropriate opportunities, and provide tailored application writing support for a wide variety of opportunities. Given the team's experience (including with health tech specifically) and the level of support, it has felt like great value for money - recommended for time limited orgs looking to maximise their opportunities."
Grace Gimson
Founder & CEO at Holly Health
Get Opportunities
with Ailsa’s
Opportunity Curator
Never miss an opportunity. Ailsa continuously discovers new grants, tenders, compititions for you 24/7, tailored to your ambition.
Get Matched
with Ailsa’s Smart
Validation Tool
Do more of what matters. Ailsa’s eligibility checker scores every opportunity for strategic fit.
Get Ready
with Ailsa’s
Application Writer
80% of the all applications written. Ailsa combines AI and expert human insight to produce high-quality applications.
